This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 34374761
Submitted by lobbyist on: September 20, 2017 12:14:19 PM
Accepted by Registrar on: September 21, 2017 09:54:41 AM
Lobbyist Information
| Mora, Ramiro |
| #4, 6 Wellesley Place | |
|
Toronto , ON, M4Y 3E1
|
416-400-5847 |
| Canada |
BC Public Office Background
Lobbyist Firm Information
| CWell Consulting Inc. |
| #4, 6 Wellesley Place | |
|
Toronto , ON, M4Y 3E1
|
416-400-5847 |
| Canada |
Client Information
| Eli Lilly Canada Inc. |
| Eli Lilly and Company is an American global pharmaceutical company which employs approximately 41,000 people and markets medicines in 120 countries. With major Research and Development facilities in six countries and clinical research conducted in more than 55 countries, Lilly is on the leading edge in many of today's most important areas of health care research. |
| 3650 Danforth Avenue | |
|
Scarborough, ON, M1N 2E8
|
416-694-3221 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| LILLY NEDERLAND HOLDING B.V. |
GROOTSLAG 1-5, 3991
HOUTEN, Netherlands |
Phone: |
Government or Government Agency Funding
Other Controlling or Directing Interests
Undertaking Information
| September 17, 2017 | |
| October 31, 2017 |
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder
Protecting Canadians from Excessive Drug Prices: Consulting on Proposed Amendments to the Patented Medicines Regulations (Federal Government Initiative) - discuss the impact on proposed federal policy changes to the PMPRB and how that will have a negative impact on vulnerable populations who benefit from low drug prices with the hope of bringing these impacts to consideration as federal policy changes move forward. Discuss government's proposed essential drugs plan.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health | September 20, 2017 | |
| Staff of Minister | Minister of Health | October 19, 2017 |
Science and Technology
Arranging meeting between an individual and a public office holder
Seeking more consultation time on the proposed changes to the Patented Medicine Prices Review Board (from Health Canada). In particular the negative impact the pricing issue - the ceiling price (i.e., list price) of patented medicines in private and public markets which will have on global/local investment (start-ups and venture capitalist), research and development, clinical trials and employment in British Columbia.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Jobs, Trade and Technology | October 25, 2017 |